Cargando…

Solifenacin/Mirabegron Induces an Acute Compliance Increase in the Filling Phase of the Capacity-Reduced Urinary Bladder: A Pressure-Volume Analysis in Rats

Aims: Pressure in the bladder, which is a high compliance organ, is only slightly elevated to a considerable filling volume during storage. Although cystometry off-line offers mean compliance, no protocol is available for real-time assays of the dynamics of bladder compliance, and the potential impa...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Hsien-Yu, Lai, Cheng-Yuan, Hsieh, Ming-Chun, Lin, Tzer-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188241/
https://www.ncbi.nlm.nih.gov/pubmed/34122078
http://dx.doi.org/10.3389/fphar.2021.657959
_version_ 1783705300009746432
author Peng, Hsien-Yu
Lai, Cheng-Yuan
Hsieh, Ming-Chun
Lin, Tzer-Bin
author_facet Peng, Hsien-Yu
Lai, Cheng-Yuan
Hsieh, Ming-Chun
Lin, Tzer-Bin
author_sort Peng, Hsien-Yu
collection PubMed
description Aims: Pressure in the bladder, which is a high compliance organ, is only slightly elevated to a considerable filling volume during storage. Although cystometry off-line offers mean compliance, no protocol is available for real-time assays of the dynamics of bladder compliance, and the potential impact of solifenacin and mirabegron on dynamic bladder compliance has not been established. Methods: Along with constantly infused cystometry, a pressure-volume analysis (PVA) was performed by plotting intra-vesical volume against pressure in Sprague-Dawley rats. The instant compliance was assayed as the slope of the trajectory, and the mean compliance (Cm) was determined by the slope of the line produced by regression of the data points at the end of the first, second, and third quarters of the filling phase. Results: Under a steady-state, the PVA trajectory moved clockwise which shaped coincident enclosed loops with stable compliance. Though administering to naïve animals solifenacin, but not mirabegron (both 1 × 10(−5)−1 × 10(−1) mg/kg, i.a.) decreased the peak pressure, both of these reagents exhibited acute increments in the trajectory slope and Cm of the filling phase in a dose-dependent manner (ED(50) = 1.4 × 10(−4) and 2.2 × 10(−5) mg/kg, respectively). Resembling urine frequency/urgency in OAB patients, the voiding frequency of a capacity-reduced bladder was increased in association with decreased compliance which was ameliorated by both acute solifenacin and mirabegron injections (both 1 × 10−1 mg/kg). Conclusion: In addition to their well-known anti-inotropic/relaxative effects, solifenacin, and mirabegron induce an acute increase in bladder compliance to ameliorate OAB-like syndromes. Together with time-domain cystometry, PVA offers a platform for investigating the physiology/pathophysiology/pharmacology of bladder compliance which is crucial for urine storage.
format Online
Article
Text
id pubmed-8188241
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81882412021-06-10 Solifenacin/Mirabegron Induces an Acute Compliance Increase in the Filling Phase of the Capacity-Reduced Urinary Bladder: A Pressure-Volume Analysis in Rats Peng, Hsien-Yu Lai, Cheng-Yuan Hsieh, Ming-Chun Lin, Tzer-Bin Front Pharmacol Pharmacology Aims: Pressure in the bladder, which is a high compliance organ, is only slightly elevated to a considerable filling volume during storage. Although cystometry off-line offers mean compliance, no protocol is available for real-time assays of the dynamics of bladder compliance, and the potential impact of solifenacin and mirabegron on dynamic bladder compliance has not been established. Methods: Along with constantly infused cystometry, a pressure-volume analysis (PVA) was performed by plotting intra-vesical volume against pressure in Sprague-Dawley rats. The instant compliance was assayed as the slope of the trajectory, and the mean compliance (Cm) was determined by the slope of the line produced by regression of the data points at the end of the first, second, and third quarters of the filling phase. Results: Under a steady-state, the PVA trajectory moved clockwise which shaped coincident enclosed loops with stable compliance. Though administering to naïve animals solifenacin, but not mirabegron (both 1 × 10(−5)−1 × 10(−1) mg/kg, i.a.) decreased the peak pressure, both of these reagents exhibited acute increments in the trajectory slope and Cm of the filling phase in a dose-dependent manner (ED(50) = 1.4 × 10(−4) and 2.2 × 10(−5) mg/kg, respectively). Resembling urine frequency/urgency in OAB patients, the voiding frequency of a capacity-reduced bladder was increased in association with decreased compliance which was ameliorated by both acute solifenacin and mirabegron injections (both 1 × 10−1 mg/kg). Conclusion: In addition to their well-known anti-inotropic/relaxative effects, solifenacin, and mirabegron induce an acute increase in bladder compliance to ameliorate OAB-like syndromes. Together with time-domain cystometry, PVA offers a platform for investigating the physiology/pathophysiology/pharmacology of bladder compliance which is crucial for urine storage. Frontiers Media S.A. 2021-05-26 /pmc/articles/PMC8188241/ /pubmed/34122078 http://dx.doi.org/10.3389/fphar.2021.657959 Text en Copyright © 2021 Peng, Lai, Hsieh and Lin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Peng, Hsien-Yu
Lai, Cheng-Yuan
Hsieh, Ming-Chun
Lin, Tzer-Bin
Solifenacin/Mirabegron Induces an Acute Compliance Increase in the Filling Phase of the Capacity-Reduced Urinary Bladder: A Pressure-Volume Analysis in Rats
title Solifenacin/Mirabegron Induces an Acute Compliance Increase in the Filling Phase of the Capacity-Reduced Urinary Bladder: A Pressure-Volume Analysis in Rats
title_full Solifenacin/Mirabegron Induces an Acute Compliance Increase in the Filling Phase of the Capacity-Reduced Urinary Bladder: A Pressure-Volume Analysis in Rats
title_fullStr Solifenacin/Mirabegron Induces an Acute Compliance Increase in the Filling Phase of the Capacity-Reduced Urinary Bladder: A Pressure-Volume Analysis in Rats
title_full_unstemmed Solifenacin/Mirabegron Induces an Acute Compliance Increase in the Filling Phase of the Capacity-Reduced Urinary Bladder: A Pressure-Volume Analysis in Rats
title_short Solifenacin/Mirabegron Induces an Acute Compliance Increase in the Filling Phase of the Capacity-Reduced Urinary Bladder: A Pressure-Volume Analysis in Rats
title_sort solifenacin/mirabegron induces an acute compliance increase in the filling phase of the capacity-reduced urinary bladder: a pressure-volume analysis in rats
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188241/
https://www.ncbi.nlm.nih.gov/pubmed/34122078
http://dx.doi.org/10.3389/fphar.2021.657959
work_keys_str_mv AT penghsienyu solifenacinmirabegroninducesanacutecomplianceincreaseinthefillingphaseofthecapacityreducedurinarybladderapressurevolumeanalysisinrats
AT laichengyuan solifenacinmirabegroninducesanacutecomplianceincreaseinthefillingphaseofthecapacityreducedurinarybladderapressurevolumeanalysisinrats
AT hsiehmingchun solifenacinmirabegroninducesanacutecomplianceincreaseinthefillingphaseofthecapacityreducedurinarybladderapressurevolumeanalysisinrats
AT lintzerbin solifenacinmirabegroninducesanacutecomplianceincreaseinthefillingphaseofthecapacityreducedurinarybladderapressurevolumeanalysisinrats